According to a survey released by the Japanese Society of Nephrology on June 30th, more than 80% of the 105 patients with impaired kidney function after taking the health product still have not recovered their kidney function despite receiving treatment.
小林制药问题保健品调查：多数患者肾功能仍未恢复
Kobayashi Pharmaceutical's survey on problem health products: Most patients' kidney function has not yet recovered.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.